Glatiramer acetate

Details

Files

Generic Name:

Glatiramer acetate

Project Status:

Complete

Therapeutic Area:

Relapsing Remitting Multiple Sclerosis (RRMS)

Manufacturer:

Pendopharm

Call for patient/clinician input open:

December 15, 2016

Brand Name:

Glatect

Project Line:

Reimbursement Review

Project Number:

SE0510-000

Call for patient/clinician input closed:

February 10, 2017

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Multiple Sclerosis, relapsing - remitting

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

July 25, 2017

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Patient Group Input Submissions View PDF

Subsequent Entry Non-Biologic Complex Drug Submission View PDF

Last Updated : December 15, 2016